China remains a magnet for foreign investment
AstraZeneca will establish its sixth global strategic R&D center at BioPark in the Beijing Economic-Technological Development Area (BDA). Photo shows a view of BioPark. (Photo from the WeChat official account of the Administrative Committee of Beijing …